Completed
An Autologous NK/CIK Cell Product (PB101) in Combination With EGFR-TKI for Treating Lung Cancer
NCT07271446
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Tri-Service General Hospital Taipei, Taiwan